Adding Medications to Triamterene-HCTZ
Add an ACE inhibitor (such as lisinopril or ramipril) or an ARB (such as losartan or valsartan) as your next agent, or alternatively add a long-acting calcium channel blocker (such as amlodipine). These are the evidence-based second-line additions when blood pressure remains uncontrolled on a thiazide diuretic combination 1.
Recommended Add-On Agents
The most current guidelines consistently recommend adding from first-line drug classes when a thiazide diuretic (which you already have with HCTZ) fails to control blood pressure:
Primary Options:
- ACE inhibitors (lisinopril, ramipril, perindopril) - Grade B evidence 1, 2
- ARBs (losartan, valsartan, telmisartan) - Grade B evidence 1, 2
- Long-acting calcium channel blockers (amlodipine, felodipine) - Grade B evidence 1, 2
The combination of a diuretic plus either an ACE inhibitor or ARB is specifically recommended as useful dual therapy 1. The combination of a calcium channel blocker with your existing diuretic also has Grade B evidence 3, 1.
Practical Algorithm
- If patient is <60 years old and non-Black: Add an ACE inhibitor 1, 2
- If patient is ≥55 years old or Black: Add a calcium channel blocker 4
- If ACE inhibitor not tolerated: Substitute an ARB 1
The 2018 Hypertension Canada guidelines upgraded the combination of a dihydropyridine calcium channel blocker with an ACE inhibitor from Grade C to Grade A evidence 1, making this an excellent choice if you select both drug classes.
Critical Contraindications
Never combine an ACE inhibitor with an ARB - this is explicitly contraindicated with Grade A evidence due to increased risk of cardiovascular events, kidney disease, and hyperkalemia 1, 2, 1, 2.
Exercise extreme caution with potassium levels since triamterene is already potassium-sparing 5. When adding an ACE inhibitor or ARB (which also increase potassium), monitor serum potassium closely. The FDA label warns against combining triamterene with ACE inhibitors due to hyperkalemia risk 5. Consider checking potassium within 1-2 weeks of adding these agents, especially if the patient has any degree of renal impairment.
If Blood Pressure Still Uncontrolled
If you need a third agent after adding one of the above:
- The preferred three-drug combination is: Diuretic + Calcium channel blocker + ACE inhibitor or ARB 1, 4, 6, 4
- This specific triple combination has the strongest evidence base across multiple guidelines 6, 7
Agents to Avoid
- Do NOT add another potassium-sparing diuretic (spironolactone, amiloride, eplerenone) - this is explicitly contraindicated with triamterene 5
- Beta-blockers are NOT first-line for uncomplicated hypertension in patients ≥60 years (Grade A) 1, 2, 1, 2
- Avoid non-dihydropyridine calcium channel blockers (diltiazem, verapamil) if you later add a beta-blocker (Grade D) 1
Monitoring Considerations
After adding any agent:
- Reassess blood pressure in 1 month (preferred) or within 1-3 months 1, 7
- Check serum potassium within 1-2 weeks if adding ACE inhibitor/ARB, especially with baseline potassium >4.5 mmol/L 3, 5
- Monitor renal function (creatinine/eGFR) when adding ACE inhibitor/ARB 8
- Target blood pressure is <140/90 mmHg for most patients 1
The evidence strongly supports that most patients with stage 2 hypertension will require at least two drug classes to achieve blood pressure control 1, 9, 7, so adding a second agent from a different class is both expected and evidence-based.